Literature DB >> 30392255

[Clinical analysis of ankle arthroscopy technique for treatment of tarsal tunnel syndrome].

S M Feng1, K F Xu, C K Li, A G Wang, Z Y Zhang.   

Abstract

Objective: To explore the effects of ankle arthroscopy technique in treating the tarsal tunnel syndrome.
Methods: From May 2014 to May 2016, the ankle arthroscopy technique was used for surgical treatment of tarsal tunnel syndrome in the Department of Hand and Foot Microsurgery in Xuzhou Central Hospital. Twenty-two patients with 24 feet with tarsal tunnel syndrome were hospitalized for treatment, with 10 left feet and 14 right feet, aged 26-57 years. The disease duration ranged from 4 to 15 months (mean 8.3 months). The dual-portals ankle arthroscopic neurolysis and fiber membrane resection were performed. The Pfeiffer scoring system was used to evaluate the post-operative outcomes.
Results: Primarily healing of the wound was achieved in all the patients. No postoperative infection was found during the follow-up. The postoperative hospitalization time was 2 to 5 days (mean 3.7 days). All patients were followed up for 12 to 24 months. At the final follow-up, all the patients had significant improvement in numbness and pain. According to the Pfeiffer scoring system, the results were excellent in 16 feet, good in 8 feet, with an excellent and good rate of 100%.
Conclusion: The ankle arthroscopic neurolysis is a safe and easy treatment option for the tarsal tunnel syndrome and provides satisfactory results.

Entities:  

Keywords:  Ankle arthroscopy; Microsurgery; Neurolysis; Tarsal tunnel syndrome

Mesh:

Year:  2018        PMID: 30392255     DOI: 10.3760/cma.j.issn.0376-2491.2018.37.009

Source DB:  PubMed          Journal:  Zhonghua Yi Xue Za Zhi        ISSN: 0376-2491


  1 in total

1.  An MRI study of the tibial nerve in the ankle canal and its branches: a method of multiplanar reformation with 3D-FIESTA-C sequences.

Authors:  Yan Zhang; Xucheng He; Juan Li; Ju Ye; Wenjuan Han; Shanshan Zhou; Jianzhong Zhu; Guisheng Wang; Xiaoxia Chen
Journal:  BMC Med Imaging       Date:  2021-03-17       Impact factor: 1.930

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.